N-丙基甲磺酰胺 | 74734-30-8

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 有机磺酸及其衍生物
• 中文名称: N-丙基甲磺酰胺
• 英文名称: N-propylmethanesulfonamide
• 英文别名: N-Propyl-methan-sulfonamid；N-Propyl-methansulfonamid
• CAS: 74734-30-8
• 化学式: C₄H₁₁NO₂S
• mdl: MFCD01212949
• 分子量: 137.203
• InChiKey: AKVITZDRJGIFAS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.2
• 重原子数：
  8
• 可旋转键数：
  3
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  54.6
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2,6-二氯异烟酸甲酯 、 N-丙基甲磺酰胺 在 tris-(dibenzylideneacetone)dipalladium(0) potassium phosphate 、 4,5-双二苯基膦-9,9-二甲基氧杂蒽 作用下， 以 1,4-二氧六环 为溶剂， 反应 16.0h， 生成 methyl 2-chloro-6-[(methylsulfonyl)(propyl)amino]isonicotinate
  参考文献：
  名称：

  WO2006/57983

  摘要：

  公开号：
• 作为产物：
  描述：

  正丙胺 、 甲基磺酰氯 在 吡啶 作用下， 以 二氯甲烷 为溶剂， 以63 %的产率得到N-丙基甲磺酰胺
  参考文献：
  名称：

  基于β-CF3-1,3-烯炔酰胺的3-三氟甲基吡咯合成

  摘要：

  开发了一种快速、高效且可规模化制备 3-三氟甲基吡咯的新无金属方法。它基于由于三氟甲基的吸电子特性和烷基伯胺的强亲核特性而导致的β-CF 3 -1,3-烯酰胺双键的亲电特性。在分离和表征丙二烯酰胺中间体后，观察到了高度区域选择性 1,4-氢胺化的证据。

  DOI：

  10.1021/acs.joc.3c01790

文献信息

• Infrared Spectra of Phenylsulfonyl Derivatives. (4). The Infrared Spectra of N-Acylsulfonamide Derivatives. (Organic Analysis. XLVIII)
  作者：Yo Ueda、Hiroshige Yano、Tsutomu Momose

  DOI：10.1248/cpb.12.5

  日期：——

  The splitting phenomenon of the carbonyl absorptions and the shifts of S-N stretching vibrations to a longer wave length region of some N-acyl-N-substituted-sulfonamide derivatives measured in solid state were described. Tertiary sulfonamides had their SO2 stretching vibrations at a shorter wave length region than secondary sulfonamides. N-Acetyl-N-alkylmethane (or ethane) sulfonamide showed strong C-N stretching vibrations of the group N-CH2-R at about 1125cm-1. N-Acyl-N-substituted-sulfonamide derivatives had very strong asymmetric stretching vibrations of the group C-CO-N at 1250∼1290cm-1. Synthesis of some sulfonamide derivatives is also described.

  在固态下测得的某些N-酰基-N-取代磺酰胺衍生物的羰基吸收分裂现象以及S-N伸缩振动向长波长区域的位移均有所描述。三级磺酰胺的SO2伸缩振动比二级磺酰胺位于更短的波长区域。N-乙酰基-N-烷基甲烷(或乙烷)磺酰胺在约1125cm-1处显示出强烈的N-CH2-R基团的C-N伸缩振动。N-酰基-N-取代磺酰胺衍生物在1250∼1290cm-1处具有非常强烈的C-CO-N基团的不对称伸缩振动。此外，还描述了一些磺酰胺衍生物的合成。
• Carbazole-Containing Sulfonamides as Cryptochrome Modulators
  申请人：Reset Therapeutics, Inc.

  公开号：US20130303524A1

  公开（公告）日：2013-11-14

  The subject matter herein is directed to carbazole-containing sulfonamide derivatives and pharmaceutically acceptable salts or hydrates thereof of structural formula I wherein the variable R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , A, B, C, D, E, F, G, H, a, and b are accordingly described. Also provided are pharmaceutical compositions comprising the compounds of formula I to treat a Cry-mediated disease or disorder, such as diabetes, obesity, metabolic syndrome, Cushing's syndrome, and glaucoma.

  本文涉及含有咔唑基磺胺衍生物及其药用可接受盐或水合物的结构式I，其中变量R1、R2、R3、R4、R5、R6、R7、A、B、C、D、E、F、G、H、a和b分别描述。还提供了包含式I化合物的药物组合物，用于治疗Cry介导的疾病或紊乱，如糖尿病、肥胖症、代谢综合征、库欣综合征和青光眼。
• Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
  申请人：Nantermet G. Philippe

  公开号：US20070088165A1

  公开（公告）日：2007-04-19

  The present invention is directed to benzylether and benzylamino derivative compounds of formula (I) which are inhibitors of the beta-secretase enzyme and that are useful in the treatment of diseases in which the beta-secretase enzyme is involved, such as Alzheimer's disease. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the treatment of such diseases in which the beta-secretase enzyme is involved.

  本发明涉及式(I)的苯甲醚和苯甲氨基衍生物化合物，它们是β-分泌酶酶的抑制剂，并且在治疗β-分泌酶酶涉及的疾病，例如阿尔茨海默病中有用。本发明还涉及包含这些化合物的制药组合物以及在治疗β-分泌酶酶涉及的疾病中使用这些化合物和组合物的用途。
• Benzylether and benzylamino beta-secretase inhibitors for the treatment of Alzheimer's disease
  申请人：Merck & Co., Inc.

  公开号：US07354942B2

  公开（公告）日：2008-04-08

  The present invention is directed to benzylether and benzylamino derivative compounds of formula (I) which are inhibitors of the beta-secretase enzyme and that are useful in the treatment of diseases in which the beta-secretase enzyme is involved, such as Alzheimer's disease. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the treatment of such diseases in which the beta-secretase enzyme is involved.

  本发明涉及式（I）的苄醚和苄氨基衍生物化合物，它们是β-分泌酶酶的抑制剂，可用于治疗β-分泌酶酶参与的疾病，如阿尔茨海默病。本发明还涉及包含这些化合物的制药组合物以及使用这些化合物和组合物治疗β-分泌酶酶参与的疾病的方法。
• Cyclic ketal beta-secretase inhibitors for the treatment of alzheimer's disease
  申请人：Merck Sharp & Dohme Corp.

  公开号：US07816378B2

  公开（公告）日：2010-10-19

  The present invention is directed to cyclic ketal compounds of formula (I) which are inhibitors of the beta-secretase enzyme and that are useful in the treatment of diseases in which the beta-secretase enzyme is involved, such as Alzheimer's disease. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the treatment of such diseases in which the beta-secretase enzyme is involved.

  本发明涉及公式（I）的环状酯化合物，它们是β-分泌酶酶的抑制剂，并且在治疗β-分泌酶酶参与的疾病，如阿尔茨海默病中有用。本发明还涉及包含这些化合物的制药组合物以及使用这些化合物和组合物治疗β-分泌酶酶参与的这些疾病的方法。